| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
|
18,771 |
16,308 |
$988K |
| 93306 |
|
15,409 |
13,309 |
$689K |
| 99233 |
Prolong inpt eval add15 m |
9,056 |
5,024 |
$290K |
| 99213 |
|
4,693 |
4,197 |
$141K |
| 99232 |
|
7,487 |
4,197 |
$136K |
| 99204 |
|
1,430 |
1,325 |
$130K |
| 99223 |
Prolong inpt eval add15 m |
1,735 |
1,436 |
$125K |
| 99222 |
|
1,713 |
1,401 |
$85K |
| 78452 |
|
425 |
369 |
$67K |
| 93297 |
|
2,489 |
2,264 |
$30K |
| 93000 |
|
10,391 |
9,434 |
$29K |
| 93295 |
|
886 |
809 |
$21K |
| 93015 |
|
1,060 |
955 |
$20K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
257 |
225 |
$18K |
| 99215 |
Prolong outpt/office vis |
196 |
183 |
$12K |
| 93296 |
|
1,786 |
1,571 |
$8K |
| J2785 |
Injection, regadenoson, 0.1 mg |
181 |
157 |
$7K |
| 93294 |
|
509 |
426 |
$6K |
| 99221 |
|
255 |
207 |
$6K |
| 93298 |
|
235 |
219 |
$5K |
| 99205 |
Prolong outpt/office vis |
25 |
25 |
$3K |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
2,424 |
2,148 |
$2K |
| 93280 |
|
28 |
25 |
$749.32 |
| 93010 |
|
146 |
74 |
$360.44 |
| 99406 |
|
28 |
26 |
$129.02 |
| 99152 |
|
38 |
27 |
$105.36 |
| 99308 |
|
181 |
44 |
$70.15 |
| Q9969 |
Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose |
80 |
68 |
$62.50 |
| 99309 |
|
114 |
32 |
$58.16 |
| 93016 |
|
21 |
17 |
$14.26 |
| 93018 |
|
21 |
17 |
$9.51 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
654 |
583 |
$0.00 |
| 93299 |
|
59 |
53 |
$0.00 |